The Organoid group at the Hubrecht Institute have identified a new link between FBXW7 mutations and EGFR signaling activity. The FBXW7 gene is commonly mutated in colorectal cancer and such mutations ...
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
Second clinical candidate from HUTCHMED’s next-generation ATTC platform - - Leveraging synergy through simultaneous inhibition of PAM pathway and EGFR signaling -HONG KONG and ...
FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with CKD and type 2 diabetes FDA also confirmed that the ongoing Phase 3 PROACT 1 ...
Implementation of a race-neutral eGFR equation contributed to more than 20,000 wait-time modifications and more kidney transplants for Black transplant candidates, according to study data published in ...
For the purpose of clarity, the signaling pathways can be discussed in isolation. However, in reality there is considerable cross-talk between pathways, with parallel or upstream input from other ...
A new study published in the Journal American Medical Association showed that patients with an Cystatin C based estimated ...
A phase II randomized placebo-controlled study of fisetin and exercise to mitigate chemotherapy-related functional decline in postmenopausal women with early breast cancer (PROFFi). This is an ASCO ...
Hutchmed begins global clinical trial of PI3K/PIKK-EGFR ATTC candidate HMPL-A580 in patients with solid tumours: Hong Kong, Shanghai Friday, March 6, 2026, 10:00 Hrs [IST] Hutchme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results